Ultragenyx Pharmaceutical
RARE
RARE
310 hedge funds and large institutions have $3.68B invested in Ultragenyx Pharmaceutical in 2024 Q4 according to their latest regulatory filings, with 55 funds opening new positions, 110 increasing their positions, 108 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
310
Holders Change
+12
Holders Change %
+4.03%
% of All Funds
4.13%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.07%
New
55
Increased
110
Reduced
108
Closed
42
Calls
$31.5M
Puts
$37.9M
Net Calls
-$6.41M
Net Calls Change
-$10.7M
Top Buyers
| 1 |
VPC
Vestal Point Capital
New York
|
$63.1M |
| 2 |
BlackRock
New York
|
$275M |
| 3 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
$27.5M |
| 4 |
Pictet Asset Management
Carouge,
Switzerland
|
$49.4M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
$49.8M |
